Trendletter18 November 2021
The Trendlines Group Trendletter | November 2021
“OrthoSpin acquired by Synthes GMBH (J&J) for $79.5M…Vensica raises $16M…liberDi & EcoPhage win awards…AlgaHealth funding on ExitValley…” Read more >
“OrthoSpin acquired by Synthes GMBH (J&J) for $79.5M…Vensica raises $16M…liberDi & EcoPhage win awards…AlgaHealth funding on ExitValley…” Read more >
OrthoSpin’s automated, digitally-enabled strut system, the AutoStrut G2 System, offers… Read more >
Funds will support clinical/regulatory development of the Vensica urology treatment platform Read more >
“Trendlines Innovation Labs collaborates with Röchling Medical…Investments in MetoMotion, CoreBone and Fidmi…AgriVest is around the corner” Read more >
Within this $800 million market, Fidmi Medical’s innovative low-profile gastrostomy system can be utilized for both initial placement and replacement and is more durable and comfortable for patients. Fidmi’s improved Read more >
The collaboration agreement leverages on the strengths of each party and on the grounds that by joining forces, the parties will… Read more >
CoreBone develops and sells bioactive bone graft material for dental and orthopedic indications. It is the only company that uses cultured coral for bone grafting. Corals are grown… Read more >
Greenhouse labor costs comprise up to 50% of total production costs. Even prior to the Covid-19 pandemic, greenhouse growers faced critical labor problems, namely increasing labor shortages and a Read more >
“Escala completes clinical trials enrollment… Equinom seals partnership… Insectta featured on CNN… PregnantTech named finalist” Read more >
“Trendlines announces $4.1 million profit and 10% increase in portfolio value for H1 2021… $7.5 million round for AgroScout… Vensica signs strategic partnership” Read more >